Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function

Clinical trial NCT04522908 · COMPLETED

Trial details

NCT number: NCT04522908
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)Second Line Treatment

Start date: 2020-10-12
Primary completion: 2024-10-04
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.